Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)

NCT06131268 is registered in ClinicalTrials.gov with Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico as lead sponsor.

NCT NCT06131268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06131268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)
Lead sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2022
Completion date
April 1, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar affective disorder, currently depressed, moderate, major depressive disorder